AtG Therapeutics was selected to present at Plug and Play’s University Pitch Sessions, joining a cohort of startups from leading universities including INSEAD, EDHEC Business School, HEC Paris Executive Education and École Polytechnique. Gabriela Jiménez pitched AtG’s work targeting tumor adaptation vulnerabilities and advancing novel therapies for advanced cancers to a distinguished academic-and-investor audience.

“It was an honor to pitch our work targeting tumor adaptation vulnerabilities, advancing novel therapies for advanced cancers, in such a distinguished forum.”